These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11373519)

  • 1. Defense mechanisms of the peritoneal cavity.
    Broche F; Tellado JM
    Curr Opin Crit Care; 2001 Apr; 7(2):105-16. PubMed ID: 11373519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and mesothelial cells in bacterial peritonitis.
    Topley N; Mackenzie RK; Williams JD
    Immunobiology; 1996 Oct; 195(4-5):563-73. PubMed ID: 8933157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resident macrophage-dependent immune cell scaffolds drive anti-bacterial defense in the peritoneal cavity.
    Vega-Pérez A; Villarrubia LH; Godio C; Gutiérrez-González A; Feo-Lucas L; Ferriz M; Martínez-Puente N; Alcaín J; Mora A; Sabio G; López-Bravo M; Ardavín C
    Immunity; 2021 Nov; 54(11):2578-2594.e5. PubMed ID: 34717795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase 2 enhances the survival of mice during Salmonella Typhimurium infection-induced sepsis by increasing reactive oxygen species, inflammatory cytokines and recruitment of neutrophils to the peritoneal cavity.
    Yadav S; Pathak S; Sarikhani M; Majumdar S; Ray S; Chandrasekar BS; Adiga V; Sundaresan NR; Nandi D
    Free Radic Biol Med; 2018 Feb; 116():73-87. PubMed ID: 29309892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation by type I interferons in the peritoneal cavity.
    Chuah JJM; Hertzog PJ; Campbell NK
    J Leukoc Biol; 2022 Feb; 111(2):337-353. PubMed ID: 34612523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR9+ macrophages are required for eradication of peritoneal bacterial infections and prevention of polymicrobial sepsis.
    Mizukami T; Kanai T; Mikami Y; Hayashi A; Doi T; Handa T; Matsumoto A; Jun L; Matsuoka K; Sato T; Hisamatsu T; Hibi T
    Immunol Lett; 2012 Sep; 147(1-2):75-9. PubMed ID: 22771342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of powder on infection risks and associated mechanisms.
    Renz H; Gemsa D
    Eur J Surg Suppl; 1997; (579):35-8. PubMed ID: 9195182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of endometrial cells in the peritoneal cavity enhances monocyte recruitment and induces inflammatory cytokines in mice: implications for endometriosis.
    Cao X; Yang D; Song M; Murphy A; Parthasarathy S
    Fertil Steril; 2004 Oct; 82 Suppl 3():999-1007. PubMed ID: 15474064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Defense mechanisms in the peritoneum].
    Szczepanik M; Gryglewski A; Solecki R
    Przegl Lek; 1999; 56(3):227-30. PubMed ID: 10442014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of the peritoneal cavity: relevance for host-tumor relation.
    Melichar B; Freedman RS
    Int J Gynecol Cancer; 2002; 12(1):3-17. PubMed ID: 11860531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The dynamics of the immune response and severity of the intoxication in peritonitis patients with open and closed management of the peritoneal cavity].
    Makhnëv AV; Kashuba EA; Egiazarian VT; Iakovenko AI; Makhnëv VA; Broder AI
    Vestn Khir Im I I Grek; 1990 Nov; 145(11):40-3. PubMed ID: 1966161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis.
    Steil AA; Garcia Rodriguez MC; Alonso A; Crespo MS; Bosca L
    Br J Pharmacol; 1995 Feb; 114(4):895-901. PubMed ID: 7539698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialized immune responses in the peritoneal cavity and omentum.
    Liu M; Silva-Sanchez A; Randall TD; Meza-Perez S
    J Leukoc Biol; 2021 Apr; 109(4):717-729. PubMed ID: 32881077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of taurolin on endogenous immunity and pathogen elimination in human peritonitis].
    Billing A; Fröhlich D; Ruckdeschel G
    Langenbecks Arch Chir; 1992; 377(3):180-5. PubMed ID: 1619980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transport barrier in intraperitoneal therapy.
    Flessner MF
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F433-42. PubMed ID: 15692055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mesothelial cells in peritoneal antibacterial defence.
    Muijsken MA; Heezius HJ; Verhoef J; Verbrugh HA
    J Clin Pathol; 1991 Jul; 44(7):600-4. PubMed ID: 1856294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis.
    Brulez HF; Verbrugh HA
    Perit Dial Int; 1995; 15(7 Suppl):S24-33; discussion S33-4. PubMed ID: 8555323
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S; Braquet P; Sirois P
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal mesothelial cells produce cytokines in a murine model of peritonitis.
    Yao V; McCauley R; Cooper D; Platell C; Hall JC
    Surg Infect (Larchmt); 2004; 5(3):229-36. PubMed ID: 15684793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.